Pathological complete response following cisplatin or carboplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis

The addition of platinum compounds to standard neoadjuvant chemotherapy (NACT) for triple-negative breast cancer (TNBC) is highly controversial. Platinum agents, such as cisplatin and carboplatin, are DNA-damaging agents which exhibit activity in breast cancer, particularly in the TNBC subgroup. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidra, Radu, Nemes, Adina, Vidrean, Andreea, Pintea, Sebastian, Tintari, Snejeana, Deac, Andrada, Ciuleanu, Tudor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652390/
https://www.ncbi.nlm.nih.gov/pubmed/34934456
http://dx.doi.org/10.3892/etm.2021.11014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652390/
https://www.ncbi.nlm.nih.gov/pubmed/34934456
http://dx.doi.org/10.3892/etm.2021.11014

Ejemplares similares